SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-042430
Filing Date
2022-11-21
Accepted
2022-11-21 10:01:40
Documents
15
Period of Report
2022-11-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10044372_8k.htm   iXBRL 8-K 61527
2 EXHIBIT 3.1 brhc10044372_ex3-1.htm EX-3.1 31301
3 EXHIBIT 3.2 brhc10044372_ex3-2.htm EX-3.2 64995
4 EXHIBIT 4.1 brhc10044372_ex4-1.htm EX-4.1 24348
  Complete submission text file 0001140361-22-042430.txt   358319

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA aeri-20221121.xsd EX-101.SCH 3875
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE aeri-20221121_lab.xml EX-101.LAB 23292
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aeri-20221121_pre.xml EX-101.PRE 16559
9 EXTRACTED XBRL INSTANCE DOCUMENT brhc10044372_8k_htm.xml XML 4395
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36152 | Film No.: 221403883
SIC: 2836 Biological Products, (No Diagnostic Substances)